Biotie Therapies

About:

Biotie is a specialized drug development company focused on the central nervous system and inflammatory diseases.

Website: http://www.biotie.com

Twitter/X: Biotie

Top Investors: Aboa Venture Management

Description:

Biotie is a specialized drug development company focused on central nervous system and inflammatory diseases. It has several innovative small molecule and biological drug candidates at different stages of clinical development. Biotie's products address diseases with high unmet medical need and significant market potential, including addiction and a broad range of inflammatory conditions such as rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S.

Total Funding Amount:

$252M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Finans, Nigde, Turkey

Founded Date:

1992-01-01

Contact Email:

info(AT)biotie.com

Founders:

Markku Jalkanen

Number of Employees:

11-50

Last Funding Date:

2015-06-01

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai